MapLight Therapeutics is a U.S.-based biotechnology company developing therapies for central nervous system and psychiatric disorders. Its work focuses on drug candidates targeting neural circuits and mechanisms involved in severe brain diseases.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!